DTect-All(TM) platform will be used to screen for GPCR-directed allosteric modulator antibodies Domain Therapeutics, a biopharmaceutical company specializing in the research and development of new drug candidates targeting G ...
Tags: DTect-All(TM)
A research group at Biocenter Oulu in Finland has identified a mechanism related to a transcription factor that binds much more strongly onto a particular SNP variant, thereby initiating a genetic programme which enhances prostate cancer ...
Tags: prostate cancer, proliferation, metastasis, SNP variations, mechanism
US-based Biozone Pharmaceuticals has announced that it has agreed to terms and signed a letter of intent (LOI) to merge with Cocrystal Discovery, a privately-held biotechnology company developing antiviral therapeutics for human diseases. ...
Oncology-focused drug development company Curis has secured US patent protecting intellectual property rights of its phosphoinositide 3-kinase (PI3K) - histone deacetylase (HDAC) inhibitor, CUDC-907. The patent covers the method of ...
Tags: Health&Medicine, Curis, US
A new UK endeavour that will focus on gaining a much better understanding of major human diseases, like cancer and other medical concerns such as deafness and ageing, is to be undertaken by an STFC-MRC consortium, thanks to a pound 1.7M ...
Tags: MRC, STFC-MRC consortium, human diseases
How quickly your skin will age? A British firm is ready to answer this question by launching the reportedly first in-store DNA tests. These tests will allow London shoppers to choose the cream and serum genetically suited to their skin ...
Tags: skin will age, test results, genetic signatures in the DNA